Clinical Trial Update: Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression

View source ↗

Summary

This update discusses teriflunomide treatment in a cohort of multiple sclerosis patients at risk of progression. The study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Aubagio (teriflunomide) (teriflunomide)

Snippet

Sponsor: Turku University Hospital | Conditions: Multiple Sclerosis | Status: ACTIVE_NOT_RECRUITING